Long-term topical bevacizumab for prevention of corneal graft rejections.

Published in: European journal of ophthalmology (2020)

Long-term use of topical 1% bevacizumab may be a safe and efficient treatment for corneal NVs and prevention of graft rejections after corneal transplantation.

Keyphrases

wound healing
optical coherence tomography
metastatic colorectal cancer
cataract surgery
cell therapy
bone marrow